{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T03:01:46Z","timestamp":1789354906300,"version":"build-2803163510"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02040-7","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T07:43:57Z","timestamp":1770536637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["LncRNA CCAT2 role in female-related cancer progression and diagnosis: a comprehensive review"],"prefix":"10.1007","volume":"26","author":[{"given":"Ahmad Ghorbani","family":"Vanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farnaz","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Ghorbaninezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parimehr","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"baharvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Raissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooya","family":"Eini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safa","family":"Tahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Safarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"issue":"4","key":"2040_CR1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/1055-9965.EPI-16-0858","volume":"26","author":"LA Torre","year":"2017","unstructured":"Torre LA, Islami F, Siegel RL, Ward EM, Jemal A. Global cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev. 2017;26(4):444\u201357.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2040_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2040_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","volume":"103","author":"J Ferlay","year":"2018","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356\u201387.","journal-title":"Eur J Cancer"},{"issue":"2","key":"2040_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","volume":"5","author":"Y Feng","year":"2018","unstructured":"Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, et al. Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes & Diseases. 2018;5(2):77\u2013106.","journal-title":"Genes & Diseases"},{"issue":"3","key":"2040_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T","volume":"67","author":"I Persson","year":"1996","unstructured":"Persson I, Yuen J, Bergkvist L, Schairer C. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy\u2013long-term follow-up of a Swedish cohort. Int J Cancer. 1996;67(3):327\u201332.","journal-title":"Int J Cancer"},{"issue":"1","key":"2040_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1750-9378-6-7","volume":"6","author":"F Aguayo","year":"2011","unstructured":"Aguayo F, Khan N, Koriyama C, Gonz\u00e1lez C, Ampuero S, Padilla O, et al. Human papillomavirus and Epstein-Barr virus infections in breast cancer from chile. Infect Agent Cancer. 2011;6(1):7.","journal-title":"Infect Agent Cancer"},{"issue":"2","key":"2040_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.bpobgyn.2005.10.010","volume":"20","author":"G Rieck","year":"2006","unstructured":"Rieck G, Fiander A. The effect of lifestyle factors on gynaecological cancer. Best Pract Res Clin Obstet Gynaecol. 2006;20(2):227\u201351.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"6","key":"2040_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023;24(6):430\u201347.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2040_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna7020036","author":"V Aliperti","year":"2021","unstructured":"Aliperti V, Skonieczna J, Cerase A. Long non-coding RNA (lncRNA) roles in cell biology, neurodevelopment and neurological disorders. Non-coding RNA. 2021. https:\/\/doi.org\/10.3390\/ncrna7020036.","journal-title":"Non-coding RNA"},{"key":"2040_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225573","author":"X Zhang","year":"2019","unstructured":"Zhang X, Wang W, Zhu W, Dong J, Cheng Y, Yin Z, et al. Mechanisms and functions of long non-coding RNAs at multiple regulatory levels. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20225573.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2040_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.gpb.2015.09.006","volume":"14","author":"Y Fang","year":"2016","unstructured":"Fang Y, Fullwood MJ. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genomics Proteomics Bioinformatics. 2016;14(1):42\u201354.","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"1","key":"2040_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV. MYC on the path to cancer. Cell. 2012;149(1):22\u201335.","journal-title":"Cell"},{"issue":"9","key":"2040_CR13","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1101\/gr.152942.112","volume":"23","author":"H Ling","year":"2013","unstructured":"Ling H, Spizzo R, Atlasi Y, Nicoloso M, Shimizu M, Redis RS, et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013;23(9):1446\u201361.","journal-title":"Genome Res"},{"issue":"4","key":"2040_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1042\/EBC20200061","volume":"65","author":"CW Yip","year":"2021","unstructured":"Yip CW, Sivaraman DM, Prabhu AV, Shin JW. Functional annotation of LncRNA in high-throughput screening. Essays Biochem. 2021;65(4):761\u201373.","journal-title":"Essays Biochem"},{"issue":"3","key":"2040_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1101\/gr.242222.118","volume":"29","author":"K Mattioli","year":"2019","unstructured":"Mattioli K, Volders PJ, Gerhardinger C, Lee JC, Maass PG, Mel\u00e9 M, et al. High-throughput functional analysis of LncRNA core promoters elucidates rules governing tissue specificity. Genome Res. 2019;29(3):344\u201355.","journal-title":"Genome Res"},{"issue":"1","key":"2040_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1769-7","volume":"17","author":"Y Liu","year":"2019","unstructured":"Liu Y, Song Y, Ye M, Hu X, Wang ZP, Zhu X. The emerging role of WISP proteins in tumorigenesis and cancer therapy. J Transl Med. 2019;17(1):28.","journal-title":"J Transl Med"},{"issue":"5","key":"2040_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211019938","volume":"49","author":"C Yang","year":"2021","unstructured":"Yang C, Li F, Zhou W, Huang J. Knockdown of long non-coding RNA CCAT2 suppresses growth and metastasis of esophageal squamous cell carcinoma by inhibiting the \u03b2-catenin\/WISP1 signaling pathway. J Int Med Res. 2021;49(5):3000605211019938.","journal-title":"J Int Med Res"},{"issue":"1","key":"2040_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"H Zhao","year":"2022","unstructured":"Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022;21(1):144.","journal-title":"Mol Cancer"},{"issue":"1","key":"2040_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.24372","volume":"54","author":"KY Chung","year":"2011","unstructured":"Chung KY, Cheng IK, Ching AK, Chu JH, Lai PB, Wong N. Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition. Hepatology. 2011;54(1):307\u201318.","journal-title":"Hepatology"},{"issue":"6","key":"2040_CR20","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1053\/j.gastro.2020.08.018","volume":"159","author":"B Chen","year":"2020","unstructured":"Chen B, Dragomir MP, Fabris L, Bayraktar R, Knutsen E, Liu X, et al. The long noncoding RNA CCAT2 induces chromosomal instability through BOP1-AURKB signaling. Gastroenterology. 2020;159(6):2146\u2013e6233.","journal-title":"Gastroenterology"},{"key":"2040_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.751903","volume":"11","author":"D Wang","year":"2021","unstructured":"Wang D, Li Z, Yin H. Long non-coding RNA CCAT2 activates RAB14 and acts as an oncogene in colorectal cancer. Front Oncol. 2021;11:751903.","journal-title":"Front Oncol"},{"issue":"2","key":"2040_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1536\/ihj.23-569","volume":"65","author":"M Zhang","year":"2024","unstructured":"Zhang M, Xu B, Li W, Yu B, Peng H, Gui F, et al. LncRNA CCAT2 protects against cardiomyocyte injury after myocardial Ischemia\/Reperfusion by regulating BMI1 expression. Int Heart J. 2024;65(2):279\u201391.","journal-title":"Int Heart J"},{"key":"2040_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.genrep.2021.101172","volume":"23","author":"M Taheri","year":"2021","unstructured":"Taheri M, Younesi Z, Moradi S, Honarmand Tamizkar K, Razjouyan K, Arsang-Jang S, et al. Altered expression of CCAT1 and CCAT2 lncRNAs in autism spectrum disorder. Gene Rep. 2021;23:101172.","journal-title":"Gene Rep"},{"issue":"1","key":"2040_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25738-6","volume":"12","author":"H Gao","year":"2022","unstructured":"Gao H, Wang X, Ma H, Lin S, Zhang D, Wu W, et al. LncRNA CCAT2, involving miR-34a\/TGF-\u03b21\/Smad4 signaling, regulate hepatic stellate cells proliferation. Sci Rep. 2022;12(1):21199.","journal-title":"Sci Rep"},{"issue":"2","key":"2040_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/agm2.12030","volume":"1","author":"J He","year":"2018","unstructured":"He J, Tu C, Liu Y. Role of LncRNAs in aging and age-related diseases. Aging Med (Milton). 2018;1(2):158\u201375.","journal-title":"Aging Med (Milton)"},{"key":"2040_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.canlet.2020.04.020","volume":"484","author":"S Jana","year":"2020","unstructured":"Jana S, Krishna M, Singhal J, Horne D, Awasthi S, Salgia R, et al. Therapeutic targeting of miRNA-216b in cancer. Cancer Lett. 2020;484:16\u201328.","journal-title":"Cancer Lett"},{"issue":"1\u20132","key":"2040_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11010-020-03712-y","volume":"468","author":"SL Sun","year":"2020","unstructured":"Sun SL, Shu YG, Tao MY. LncRNA CCAT2 promotes angiogenesis in glioma through activation of VEGFA signalling by sponging miR-424. Mol Cell Biochem. 2020;468(1\u20132):69\u201382.","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"2040_CR28","first-page":"241","volume":"26","author":"F Hua","year":"2018","unstructured":"Hua F, Li CH, Chen XG, Liu XP. Long noncoding RNA CCAT2 knockdown suppresses tumorous progression by sponging miR-424 in epithelial ovarian cancer. Oncol Res Featuring Preclin Clin Cancer Ther. 2018;26(2):241\u20137.","journal-title":"Oncol Res Featuring Preclin Clin Cancer Ther"},{"key":"2040_CR29","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.2147\/OTT.S227831","volume":"13","author":"J Ding","year":"2020","unstructured":"Ding J, Zhang L, Chen S, Cao H, Xu C, Wang X. LncRNA CCAT2 enhanced resistance of glioma cells against chemodrugs by disturbing the normal function of miR-424. Onco Targets Ther. 2020;13:1431\u201345.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"2040_CR30","doi-asserted-by":"publisher","first-page":"6264","DOI":"10.1080\/21655979.2021.1969834","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J, Liu Y, Cai H, Jiang H, Li W, Shi Y. Long coding RNA CCAT2 enhances the proliferation and epithelial-mesenchymal transition of cervical carcinoma cells via the microRNA-493-5p\/CREB1 axis. Bioengineered. 2021;12(1):6264\u201374.","journal-title":"Bioengineered"},{"issue":"1","key":"2040_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10238-025-01730-y","volume":"25","author":"AG Vanan","year":"2025","unstructured":"Vanan AG, Ghorbaninezhad F, Nikeghbali G, Mohamadi F, Ayati A, Mastani RG, et al. CCAT2 role in Gastrointestinal cancer progression and metastasis: a novel target for therapeutic strategies. Clin Experimental Med. 2025;25(1):197.","journal-title":"Clin Experimental Med"},{"issue":"5","key":"2040_CR32","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"key":"2040_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cca.2017.03.003","volume":"468","author":"X Jing","year":"2017","unstructured":"Jing X, Liang H, Cui X, Han C, Hao C, Huo K. Long noncoding RNA CCAT2 can predict metastasis and a poor prognosis: a meta-analysis. Clin Chim Acta. 2017;468:159\u201365.","journal-title":"Clin Chim Acta"},{"issue":"6","key":"2040_CR34","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/wrr.12490","volume":"24","author":"J Yu","year":"2016","unstructured":"Yu J, Lu S, McLaren AM, Perry JA, Cross KM. Topical oxygen therapy results in complete wound healing in diabetic foot ulcers. Wound Repair Regen. 2016;24(6):1066\u201372.","journal-title":"Wound Repair Regen"},{"issue":"5","key":"2040_CR35","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1055\/s-0036-1592173","volume":"37","author":"HH Sun","year":"2016","unstructured":"Sun HH, Sesti J, Donington JS. Surgical treatment of early l stage lung cancer: what has changed and what will change in the future. Semin Respir Crit Care Med. 2016;37(5):708\u201315.","journal-title":"Semin Respir Crit Care Med"},{"issue":"46","key":"2040_CR36","doi-asserted-by":"publisher","first-page":"74947","DOI":"10.18632\/oncotarget.12509","volume":"7","author":"G Mincione","year":"2016","unstructured":"Mincione G, Di Marcantonio MC, Tarantelli C, Savino L, Ponti D, Marchisio M, et al. Identification of the zinc finger 216 (ZNF216) in human carcinoma cells: a potential regulator of EGFR activity. Oncotarget. 2016;7(46):74947\u201365.","journal-title":"Oncotarget"},{"issue":"10","key":"2040_CR37","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.4254\/wjh.v7.i10.1412","volume":"7","author":"KW Chen","year":"2015","unstructured":"Chen KW, Ou TM, Hsu CW, Horng CT, Lee CC, Tsai YY, et al. Current systemic treatment of hepatocellular carcinoma: A review of the literature. World J Hepatol. 2015;7(10):1412\u201320.","journal-title":"World J Hepatol"},{"issue":"47","key":"2040_CR38","doi-asserted-by":"publisher","first-page":"76726","DOI":"10.18632\/oncotarget.12521","volume":"7","author":"K Taran","year":"2016","unstructured":"Taran K, Fr\u0105czek T, Sikora-Szubert A, Sitkiewicz A, M\u0142ynarski W, Kobos J, et al. The first investigation of Wilms\u2019 tumour atomic structure-nitrogen and carbon isotopic composition as a novel biomarker for the most individual approach in cancer disease. Oncotarget. 2016;7(47):76726\u201334.","journal-title":"Oncotarget"},{"issue":"1","key":"2040_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10238-025-01711-1","volume":"25","author":"A Ghorbani vanan","year":"2025","unstructured":"Ghorbani vanan A, Nami MT, Ghorbaninezhad F, Eini P, Bagheri K, Mohammadlou M, et al. Macrophage polarization in hepatocellular carcinoma: a lncRNA-centric perspective on tumor progression and metastasis. Clin Experimental Med. 2025;25(1):173.","journal-title":"Clin Experimental Med"},{"issue":"1","key":"2040_CR40","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12935-025-04017-0","volume":"25","author":"F Ghorbaninezhad","year":"2025","unstructured":"Ghorbaninezhad F, Vanan AG, Rostami S, Vaezi F, Doachi R, Hafshejani ZA, et al. Long non-coding RNAs: key orchestrators of macrophage polarization in breast cancer. Cancer Cell Int. 2025;25(1):372.","journal-title":"Cancer Cell Int"},{"key":"2040_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/biom15111564","author":"S Tahmasebi","year":"2025","unstructured":"Tahmasebi S, Amani D, Salimi B, Adcock IM, Mortaz E. LncRNA-mediated miR-145 sponging drives FN1 and CCND1 expression: prognostic and therapeutic targets in NSCLC. Biomolecules. 2025. https:\/\/doi.org\/10.3390\/biom15111564.","journal-title":"Biomolecules"},{"issue":"4","key":"2040_CR42","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s11010-020-04042-9","volume":"476","author":"M Chen","year":"2021","unstructured":"Chen M, Zhao M, Hou Y, Zhu B. Expression of LncRNA CCAT2 in children with neuroblastoma and its effect on cancer cell growth. Mol Cell Biochem. 2021;476(4):1871\u20139.","journal-title":"Mol Cell Biochem"},{"issue":"23","key":"2040_CR43","first-page":"12224","volume":"24","author":"W Fu","year":"2020","unstructured":"Fu W, Wang XD, Ye JD, Jin J, Chen L, Qi QY. CCAT2 contributes to progression and treatment resistance of thyroid carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(23):12224\u201331.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"2040_CR44","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.3892\/ijmm.2020.4761","volume":"46","author":"S Xin","year":"2020","unstructured":"Xin S, Ye X. Knockdown of long non\u2013coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt\/\u03b2\u2013catenin pathway. Int J Mol Med. 2020;46(6):2047\u201356.","journal-title":"Int J Mol Med"},{"issue":"4","key":"2040_CR45","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.bbrc.2016.08.120","volume":"480","author":"J Zheng","year":"2016","unstructured":"Zheng J, Zhao S, He X, Zheng Z, Bai W, Duan Y, et al. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition. Biochem Biophys Res Commun. 2016;480(4):508\u201314.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2040_CR46","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.11958","volume":"20","author":"P He","year":"2020","unstructured":"He P, Xiong G, Guo W, Jiang G, Li Y, Li H. Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt\/\u03b2-catenin signaling pathway. Oncol Lett. 2020;20(4):97.","journal-title":"Oncol Lett"},{"issue":"23","key":"2040_CR47","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1097\/CM9.0000000000002286","volume":"135","author":"S Ma","year":"2022","unstructured":"Ma S, Wang W, Zhang D, Zhao G, Lu Z. Long non-coding RNA colon cancer-associated transcript 2: role and function in human cancers. Chin Med J (Engl). 2022;135(23):2785\u201397.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"2040_CR48","first-page":"245","volume":"8","author":"D Fu","year":"2018","unstructured":"Fu D, Zhang Y, Cui H. Long noncoding RNA CCAT2 is activated by E2F1 and exerts oncogenic properties by interacting with PTTG1 in pituitary adenomas. Am J Cancer Res. 2018;8(2):245\u201355.","journal-title":"Am J Cancer Res"},{"issue":"7","key":"2040_CR49","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317717670","volume":"39","author":"Y Ma","year":"2017","unstructured":"Ma Y, Hu X, Shang C, Zhong M, Guo Y. Silencing of long non-coding RNA CCAT2 depressed malignancy of oral squamous cell carcinoma via Wnt\/\u03b2-catenin pathway. Tumour Biol. 2017;39(7):1010428317717670.","journal-title":"Tumour Biol"},{"issue":"44","key":"2040_CR50","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1039\/C6TB02014C","volume":"4","author":"J Wei","year":"2016","unstructured":"Wei J, Lu J, Liu Y, Yan S, Li X. Spheroid culture of primary hepatocytes with short fibers as a predictable in vitro model for drug screening. J Mater Chem B. 2016;4(44):7155\u201367.","journal-title":"J Mater Chem B"},{"issue":"20","key":"2040_CR51","doi-asserted-by":"publisher","first-page":"28989","DOI":"10.18632\/oncotarget.8259","volume":"7","author":"J Li","year":"2016","unstructured":"Li J, Zhuang C, Liu Y, Chen M, Zhou Q, Chen Z, et al. Shrna targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells. Oncotarget. 2016;7(20):28989\u201397.","journal-title":"Oncotarget"},{"issue":"10","key":"2040_CR52","first-page":"944","volume":"55","author":"SK Zhou","year":"2020","unstructured":"Zhou SK, Gao F, Zhong ZS, Yao H. [Long non-coding RNA colon cancer associated transcript-2 from nasopharyngeal carcinoma-derived exosomes promotes angiogenesis]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020;55(10):944\u201351.","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"issue":"3","key":"2040_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12342","volume":"50","author":"Y Xin","year":"2017","unstructured":"Xin Y, Li Z, Zheng H, Chan MT, Ka Kei Wu W. CCAT 2: a novel oncogenic long non-coding RNA in human cancers. Cell Prolif. 2017;50(3):e12342.","journal-title":"Cell Prolif"},{"issue":"1","key":"2040_CR54","first-page":"11","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2040_CR55","first-page":"138","volume":"49","author":"C Mettlin","year":"1999","unstructured":"Mettlin C. Global breast cancer mortality statistics. CA Cancer J Clin. 1999;49(3):138\u201344.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"2040_CR56","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.18632\/oncotarget.1292","volume":"4","author":"RS Redis","year":"2013","unstructured":"Redis RS, Sieuwerts AM, Look MP, Tudoran O, Ivan C, Spizzo R, et al. CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations. Oncotarget. 2013;4(10):1748.","journal-title":"Oncotarget"},{"key":"2040_CR57","first-page":"2657","volume":"8","author":"Y Cai","year":"2015","unstructured":"Cai Y, He J, Zhang D. Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway. Onco Targets Ther. 2015;8:2657\u201364.","journal-title":"Onco Targets Ther"},{"key":"2040_CR58","doi-asserted-by":"publisher","first-page":"121183","DOI":"10.1016\/j.lfs.2022.121183","volume":"311Pt B","author":"F Moradi","year":"2022","unstructured":"Moradi F, Mohajerani F, Sadeghizadeh M. CCAT2 knockdown inhibits cell growth, and migration and promotes apoptosis through regulating the hsa-mir-145-5p\/AKT3\/mTOR axis in tamoxifen-resistant MCF7 cells. Life Sci. 2022;311Pt B:121183.","journal-title":"Life Sci"},{"key":"2040_CR59","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1134\/S0026893316030043","volume":"50","author":"Y Caia","year":"2016","unstructured":"Caia Y, He J, Zhang D. Suppression of long non-coding RNA CCAT2 improves tamoxifen-resistant breast cancer cells\u2019 response to tamoxifen. Mol Biol. 2016;50:725\u201330.","journal-title":"Mol Biol"},{"key":"2040_CR60","doi-asserted-by":"publisher","first-page":"155946","DOI":"10.1016\/j.prp.2025.155946","volume":"269","author":"E Alaei","year":"2025","unstructured":"Alaei E, Hashemi F, Farahani N, Tahmasebi S, Nabavi N, Daneshi S, et al. Peptides in breast cancer therapy: from mechanisms to emerging drug delivery and immunotherapy strategies. Pathol - Res Pract. 2025;269:155946.","journal-title":"Pathol - Res Pract"},{"issue":"1","key":"2040_CR61","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13058-025-02136-0","volume":"27","author":"F Norouzi","year":"2025","unstructured":"Norouzi F, Eini P, Tahmasebi S. The role of NETosis in breast cancer: mechanistic insights and biomarker potential. Breast Cancer Res. 2025;27(1):180.","journal-title":"Breast Cancer Res"},{"key":"2040_CR62","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.biopha.2017.05.030","volume":"91","author":"X Deng","year":"2017","unstructured":"Deng X, Zhao Y, Wu X, Song G. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer. Biomed Pharmacother. 2017;91:1160\u20136.","journal-title":"Biomed Pharmacother"},{"key":"2040_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104628","volume":"152","author":"Z Xu","year":"2020","unstructured":"Xu Z, Liu C, Zhao Q, L\u00fc J, Ding X, Luo A, et al. Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells. Pharmacol Res. 2020;152:104628.","journal-title":"Pharmacol Res"},{"issue":"1","key":"2040_CR64","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13048-022-00950-0","volume":"15","author":"X Cao","year":"2022","unstructured":"Cao X, Yao J, Jia M, Shen X, Zhang J, Ju S. Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer. J Ovarian Res. 2022;15(1):20.","journal-title":"J Ovarian Res"},{"issue":"10","key":"2040_CR65","first-page":"13261","volume":"8","author":"X Chen","year":"2015","unstructured":"Chen X, Liu L, Zhu W. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients. Int J Clin Exp Pathol. 2015;8(10):13261\u20136.","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"2040_CR66","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00404-018-4740-6","volume":"297","author":"S \u0141a\u017aniak","year":"2018","unstructured":"\u0141a\u017aniak S, Lutkowska A, Ware\u0144czak-Florczak \u017b, Sowi\u0144ska A, Tsibulski A, Roszak A, et al. The association of CCAT2 rs6983267 SNP with MYC expression and progression of uterine cervical cancer in the Polish population. Arch Gynecol Obstet. 2018;297(5):1285\u201392.","journal-title":"Arch Gynecol Obstet"},{"key":"2040_CR67","doi-asserted-by":"publisher","first-page":"875","DOI":"10.12659\/MSM.897754","volume":"22","author":"L Wu","year":"2016","unstructured":"Wu L, Jin L, Zhang W, Zhang L. Roles of long non-coding RNA CCAT2 in cervical cancer cell growth and apoptosis. Med Sci Monit. 2016;22:875\u20139.","journal-title":"Med Sci Monit"},{"key":"2040_CR68","doi-asserted-by":"publisher","first-page":"9495","DOI":"10.2147\/CMAR.S259586","volume":"12","author":"WJ Wang","year":"2020","unstructured":"Wang WJ, Wang D, Zhao M, Sun XJ, Li Y, Lin H, et al. Serum lncRNAs (CCAT2, LINC01133, LINC00511) with squamous cell carcinoma antigen panel as novel non-invasive biomarkers for detection of cervical squamous carcinoma. Cancer Manag Res. 2020;12:9495\u2013502.","journal-title":"Cancer Manag Res"},{"key":"2040_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072334","author":"L Wang","year":"2020","unstructured":"Wang L, Zhou S, Guo B. Vitamin D suppresses ovarian cancer growth and invasion by targeting long non-coding RNA CCAT2. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21072334.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2040_CR70","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13000-016-0499-x","volume":"11","author":"S Huang","year":"2016","unstructured":"Huang S, Qing C, Huang Z, Zhu Y. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis. Diagn Pathol. 2016;11(1):49.","journal-title":"Diagn Pathol"},{"issue":"6","key":"2040_CR71","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s10517-022-05473-8","volume":"172","author":"OI Brovkina","year":"2022","unstructured":"Brovkina OI, Pronina IV, Burdennyy AM, Uroshlev LA, Filippova EA, Fridman MV, et al. The role of long non-coding RNA CCAT1 and SNHG14 in activation of some protein-coding genes associated with the development of ovarian cancer. Bull Exp Biol Med. 2022;172(6):760\u20134.","journal-title":"Bull Exp Biol Med"},{"issue":"3","key":"2040_CR72","first-page":"3369","volume":"15","author":"B Wang","year":"2018","unstructured":"Wang B, Liu M, Zhuang R, Jiang J, Gao J, Wang H, et al. Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt\/\u03b2-catenin pathway in epithelial ovarian carcinoma cells. Oncol Lett. 2018;15(3):3369\u201375.","journal-title":"Oncol Lett"},{"issue":"12","key":"2040_CR73","first-page":"11771","volume":"10","author":"BD Wang","year":"2017","unstructured":"Wang BD, Jiang J, Liu MM, Zhuang RJ, Wang H, Li PL. Silencing CCAT2 inhibited proliferation and invasion of epithelial ovarian carcinoma cells by regulating Wnt signaling pathway. Int J Clin Exp Pathol. 2017;10(12):11771\u20138.","journal-title":"Int J Clin Exp Pathol"},{"issue":"9","key":"2040_CR74","doi-asserted-by":"publisher","first-page":"7904","DOI":"10.3390\/curroncol30090574","volume":"30","author":"TM Kuhn","year":"2023","unstructured":"Kuhn TM, Dhanani S, Ahmad S. An overview of endometrial cancer with novel therapeutic strategies. Curr Oncol. 2023;30(9):7904\u201319.","journal-title":"Curr Oncol"},{"issue":"1","key":"2040_CR75","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/CBM-170388","volume":"21","author":"P Xie","year":"2017","unstructured":"Xie P, Cao H, Li Y, Wang J, Cui Z. Knockdown of LncRNA CCAT2 inhibits endometrial cancer cells growth and metastasis via sponging miR-216b. Cancer Biomark. 2017;21(1):123\u201333.","journal-title":"Cancer Biomark"},{"issue":"9","key":"2040_CR76","first-page":"4376","volume":"13","author":"J Li","year":"2023","unstructured":"Li J, Ramzan F, Zhong G. Investigating novel biomarkers in uterine corpus endometrial carcinoma: in silico analysis and clinical specimens validation via RT-qPCR and immunohistochemistry. Am J Cancer Res. 2023;13(9):4376\u2013400.","journal-title":"Am J Cancer Res"},{"issue":"5","key":"2040_CR77","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s12192-018-0899-9","volume":"23","author":"M Cai","year":"2018","unstructured":"Cai M, Hu Y, Zheng T, He H, Xiao W, Liu B, et al. MicroRNA-216b inhibits heat stress-induced cell apoptosis by targeting Fas in bovine mammary epithelial cells. Cell Stress Chaperones. 2018;23(5):921\u201331.","journal-title":"Cell Stress Chaperones"},{"issue":"2","key":"2040_CR78","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/cancers11020234","volume":"11","author":"P Dong","year":"2019","unstructured":"Dong P, Xiong Y, Yue J, JB Hanley S, Kobayashi N, Todo Y, et al. Exploring lncRNA-mediated regulatory networks in endometrial cancer cells and the tumor microenvironment: advances and challenges. Cancers. 2019;11(2):234.","journal-title":"Cancers"},{"key":"2040_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ncrna.2024.08.002","volume":"10","author":"M Hashemi","year":"2025","unstructured":"Hashemi M, Khosroshahi EM, Asadi S, Tanha M, Mohseni FG, Sagha RA, et al. Emerging roles of non-coding RNAs in modulating the PI3K\/Akt pathway in cancer. Non-coding RNA Res. 2025;10:1\u201315.","journal-title":"Non-coding RNA Res"},{"issue":"1","key":"2040_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0671-2","volume":"16","author":"ES Hosseini","year":"2017","unstructured":"Hosseini ES, Meryet-Figuiere M, Sabzalipoor H, Kashani HH, Nikzad H, Asemi Z. Dysregulated expression of long noncoding RNAs in gynecologic cancers. Mol Cancer. 2017;16(1):107.","journal-title":"Mol Cancer"},{"issue":"9","key":"2040_CR81","first-page":"4376","volume":"13","author":"J Li","year":"2023","unstructured":"Li J, Ramzan F, Zhong G. Investigating novel biomarkers in uterine corpus endometrial carcinoma: in silico analysis and clinical specimens validation via RT-qPCR and immunohistochemistry. Am J Cancer Res. 2023;13(9):4376.","journal-title":"Am J Cancer Res"},{"issue":"14","key":"2040_CR82","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.18632\/oncotarget.2116","volume":"5","author":"L Wang","year":"2014","unstructured":"Wang L, Shi ZM, Jiang CF, Liu X, Chen QD, Qian X, et al. MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma. Oncotarget. 2014;5(14):5416\u201327.","journal-title":"Oncotarget"},{"key":"2040_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084432","author":"A Shrestha","year":"2024","unstructured":"Shrestha A, Lahooti B, Hossian A, Madadi M, Mikelis CM, Mattheolabakis G. Stable dual miR-143 and miR-506 upregulation inhibits proliferation and cell cycle progression. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25084432.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2040_CR84","doi-asserted-by":"publisher","first-page":"20577","DOI":"10.1002\/jcp.28661","volume":"234","author":"D Che","year":"2019","unstructured":"Che D, Huang W, Fang Z, Li L, Wu H, Pi L, et al. The lncRNA CCAT2 rs6983267 G allele is associated with decreased susceptibility to recurrent miscarriage. J Cell Physiol. 2019;234(11):20577\u201383.","journal-title":"J Cell Physiol"},{"issue":"3","key":"2040_CR85","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/ng749","volume":"29","author":"J Ioannidis","year":"2001","unstructured":"Ioannidis J, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet. 2001;29(3):306\u20139.","journal-title":"Nat Genet"},{"issue":"6","key":"2040_CR86","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/ng1805","volume":"38","author":"EM Valente","year":"2006","unstructured":"Valente EM, Silhavy JL, Brancati F, Barrano G, Krishnaswami SR, Castori M, et al. Mutations in CEP290, which encodes a centrosomal protein, cause pleiotropic forms of Joubert syndrome. Nat Genet. 2006;38(6):623\u20135.","journal-title":"Nat Genet"},{"issue":"23","key":"2040_CR87","doi-asserted-by":"publisher","first-page":"9362","DOI":"10.1073\/pnas.0903103106","volume":"106","author":"LA Hindorff","year":"2009","unstructured":"Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci. 2009;106(23):9362\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"2040_CR88","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41576-019-0127-1","volume":"20","author":"V Tam","year":"2019","unstructured":"Tam V, Patel N, Turcotte M, Boss\u00e9 Y, Par\u00e9 G, Meyre D. Benefits and limitations of genome-wide association studies. Nat Rev Genet. 2019;20(8):467\u201384.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"2040_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02200-2","volume":"10","author":"H Goyal","year":"2024","unstructured":"Goyal H, Parwani S, Kaur J. Deciphering the nexus between long non-coding RNAs and endoplasmic reticulum stress in hepatocellular carcinoma: biomarker discovery and therapeutic horizons. Cell Death Discov. 2024;10(1):451.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2040_CR90","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-01848-1","volume":"16","author":"N Afroze","year":"2025","unstructured":"Afroze N, Sundaram MK, Haque S, Hussain A. Long non-coding RNA involved in the carcinogenesis of human female cancer - a comprehensive review. Discov Oncol. 2025;16(1):122.","journal-title":"Discov Oncol"},{"issue":"3","key":"2040_CR91","doi-asserted-by":"publisher","first-page":"439","DOI":"10.5603\/rpor.106487","volume":"30","author":"C Saini","year":"2025","unstructured":"Saini C, Vats P, Maharshi S, Baweja B, Nema R. Involvement of LncRNA in cancer diagnosis and prognosis and clinical implications. Rep Pract Oncol Radiother. 2025;30(3):439\u201350.","journal-title":"Rep Pract Oncol Radiother"},{"issue":"1","key":"2040_CR92","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10238-025-01730-y","volume":"25","author":"AG Vanan","year":"2025","unstructured":"Vanan AG, Ghorbaninezhad F, Nikeghbali G, Mohamadi F, Ayati A, Mastani RG, et al. CCAT2 role in Gastrointestinal cancer progression and metastasis: a novel target for therapeutic strategies. Clin Exp Med. 2025;25(1):197.","journal-title":"Clin Exp Med"},{"issue":"5","key":"2040_CR93","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1111\/jcmm.17041","volume":"26","author":"D Zhou","year":"2022","unstructured":"Zhou D, Gu J, Wang Y, Luo B, Feng M, Wang X. Long noncoding RNA CCAT2 reduces chemosensitivity to 5-fluorouracil in breast cancer cells by activating the mTOR axis. J Cell Mol Med. 2022;26(5):1392\u2013401.","journal-title":"J Cell Mol Med"},{"key":"2040_CR94","unstructured":"Wu Z-J, Li Y, Wu Y-Z, Wang Y, Nian W-Q, Wang L-L et al. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-\u03b2 signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(4)."},{"key":"2040_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.878529","volume":"12","author":"Y Feng","year":"2022","unstructured":"Feng Y, Wang Z, Zhu M, Li S, Dong S, Gong L, et al. Single nucleotide polymorphisms of EXOC1, BCL2, CCAT2, and CARD8 genes and susceptibility to cervical cancer in the northern Chinese Han population. Front Oncol. 2022;12:878529.","journal-title":"Front Oncol"},{"issue":"7","key":"2040_CR96","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1166\/jbt.2022.3044","volume":"12","author":"J Zhou","year":"2022","unstructured":"Zhou J, Wang X, Han Y, Chu Q, Zheng Y. LncRNA-CCAT2 reduces the drug resistance of ovarian cancer cells. J Biomater Tissue Eng. 2022;12(7):1417\u201322.","journal-title":"J Biomater Tissue Eng"},{"issue":"11","key":"2040_CR97","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23176","volume":"36","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Wang X, Wang Y, Zhou D, Wu H, Cheng W, et al. Effect of long noncoding RNA CCAT2 on drug sensitivity to 5-fluorouracil of breast cancer cells through microRNA\u2010145 meditated by p53. J Biochem Mol Toxicol. 2022;36(11):e23176.","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"2040_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020538","volume":"15","author":"H Xie","year":"2023","unstructured":"Xie H, Guo Y, Xu Z, Wang Q, Wang T, Gu Y, et al. Dual function of CCAT2 in regulating luminal subtype of breast cancer depending on the subcellular distribution. Cancers. 2023;15(2):538.","journal-title":"Cancers"},{"key":"2040_CR99","doi-asserted-by":"publisher","first-page":"875","DOI":"10.12659\/MSM.897754","volume":"22","author":"L Wu","year":"2016","unstructured":"Wu L, Jin L, Zhang W, Zhang L. Roles of long non-coding RNA CCAT2 in cervical cancer cell growth and apoptosis. Med Sci Monitor: Int Med J Experimental Clin Res. 2016;22:875.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"issue":"1","key":"2040_CR100","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1101\/gad.270959.115","volume":"30","author":"G Arun","year":"2016","unstructured":"Arun G, Diermeier S, Akerman M, Chang K-C, Wilkinson JE, Hearn S, et al. Differentiation of mammary tumors and reduction in metastasis upon Malat1 LncRNA loss. Genes Dev. 2016;30(1):34\u201351.","journal-title":"Genes Dev"},{"issue":"12","key":"2040_CR101","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/s41588-018-0252-3","volume":"50","author":"J Kim","year":"2018","unstructured":"Kim J, Piao H-L, Kim B-J, Yao F, Han Z, Wang Y, et al. Long noncoding RNA MALAT1 suppresses breast cancer metastasis. Nat Genet. 2018;50(12):1705\u201315.","journal-title":"Nat Genet"},{"issue":"1","key":"2040_CR102","volume":"2020","author":"B Huang","year":"2020","unstructured":"Huang B, Yu M, Guan R, Liu D, Hou B. A comprehensive exploration of the lncRNA CCAT2: a pan-cancer analysis based on 33 cancer types and 13285 cases. Dis Markers. 2020;2020(1):5354702.","journal-title":"Dis Markers"},{"issue":"4","key":"2040_CR103","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12594","volume":"21","author":"F-H Qiao","year":"2021","unstructured":"Qiao F-H, Tu M, Liu H-Y. Role of MALAT1 in gynecological cancers: pathologic and therapeutic aspects. Oncol Lett. 2021;21(4):333.","journal-title":"Oncol Lett"},{"key":"2040_CR104","unstructured":"Yang L, Bai H-S, Deng Y, Fan L. High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion. Eur Rev Med Pharmacol Sci. 2015;19(17)."},{"issue":"12","key":"2040_CR105","first-page":"11771","volume":"10","author":"B-D Wang","year":"2017","unstructured":"Wang B-D, Jiang J, Liu M-M, Zhuang R-J, Wang H, Li P-L. Silencing CCAT2 inhibited proliferation and invasion of epithelial ovarian carcinoma cells by regulating Wnt signaling pathway. Int J Clin Exp Pathol. 2017;10(12):11771.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"2040_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5603\/GP.a2021.0079","volume":"93","author":"H Ma","year":"2022","unstructured":"Ma H, Gao L, Yu H, Song X. Long non-coding RNA H19 correlates with unfavorable prognosis and promotes cell migration and invasion in ovarian cancer. Ginekol Pol. 2022;93(1):1\u20136.","journal-title":"Ginekol Pol"},{"issue":"1","key":"2040_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11743-z","volume":"24","author":"M Ghasemian","year":"2024","unstructured":"Ghasemian M, Zehtabi M, Dari MAG, Pour FK, Tabesh GA, Moramezi F, et al. The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers. BMC Cancer. 2024;24(1):4.","journal-title":"BMC Cancer"},{"issue":"2","key":"2040_CR108","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3892\/or.2017.5742","volume":"38","author":"H-L Lang","year":"2017","unstructured":"Lang H-L, Hu G-W, Zhang B, Kuang W, Chen Y, Wu L, et al. Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2. Oncol Rep. 2017;38(2):785\u201398.","journal-title":"Oncol Rep"},{"issue":"10","key":"2040_CR109","first-page":"944","volume":"55","author":"S Zhou","year":"2020","unstructured":"Zhou S, Gao F, Zhong Z, Yao H. Long non-coding RNA colon cancer associated transcript-2 from nasopharyngeal carcinoma-derived exosomes promotes angiogenesis. Zhonghua er bi yan hou tou jing wai ke za zhi\u2009=\u2009Chinese journal of otorhinolaryngology head and neck surgery. 2020;55(10):944\u201351.","journal-title":"Zhonghua er bi yan hou tou jing wai ke za zhi\u2009=\u2009Chinese journal of otorhinolaryngology head and neck surgery"},{"issue":"10","key":"2040_CR110","doi-asserted-by":"publisher","first-page":"16885","DOI":"10.1002\/jcp.28374","volume":"234","author":"C Aslan","year":"2019","unstructured":"Aslan C, Maralbashi S, Salari F, Kahroba H, Sigaroodi F, Kazemi T, et al. Tumor-derived exosomes: implication in angiogenesis and antiangiogenesis cancer therapy. J Cell Physiol. 2019;234(10):16885\u2013903.","journal-title":"J Cell Physiol"},{"issue":"20","key":"2040_CR111","doi-asserted-by":"publisher","first-page":"11656","DOI":"10.1111\/jcmm.15873","volume":"24","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang M, Zhou F. Biological functions and clinical applications of exosomal long non-coding RNAs in cancer. J Cell Mol Med. 2020;24(20):11656\u201366.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"2040_CR112","doi-asserted-by":"publisher","first-page":"e0250717","DOI":"10.1371\/journal.pone.0250717","volume":"16","author":"L Zhang","year":"2021","unstructured":"Zhang L, Hu C, Huang Z, Li Z, Zhang Q, He Y. In silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: a comprehensive meta-analysis. PLoS One. 2021;16(4):e0250717.","journal-title":"PLoS One"},{"issue":"1","key":"2040_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23938-8","volume":"12","author":"B El-Helkan","year":"2022","unstructured":"El-Helkan B, Emam M, Mohanad M, Fathy S, Zekri AR, Ahmed OS. Long non-coding RNAs as novel prognostic biomarkers for breast cancer in Egyptian women. Sci Rep. 2022;12(1):19498.","journal-title":"Sci Rep"},{"issue":"2","key":"2040_CR114","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3727\/096504017X14953948675412","volume":"26","author":"F Hua","year":"2018","unstructured":"Hua F, Li C-H, Chen X-G, Liu X-P. Long noncoding RNA CCAT2 knockdown suppresses tumorous progression by sponging miR-424 in epithelial ovarian cancer. Oncol Res. 2018;26(2):241.","journal-title":"Oncol Res"},{"issue":"1","key":"2040_CR115","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ygyno.2013.07.094","volume":"131","author":"B Kristjansdottir","year":"2013","unstructured":"Kristjansdottir B, Levan K, Partheen K, Sundfeldt K. Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer. Gynecol Oncol. 2013;131(1):52\u20138.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"2040_CR116","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","volume":"104","author":"T Van Gorp","year":"2011","unstructured":"Van Gorp T, Cadron I, Despierre E, Daemen A, Leunen K, Amant F, et al. HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the risk of ovarian malignancy algorithm. Br J Cancer. 2011;104(5):863\u201370.","journal-title":"Br J Cancer"},{"issue":"3","key":"2040_CR117","doi-asserted-by":"publisher","first-page":"337","DOI":"10.5468\/ogs.2018.61.3.337","volume":"61","author":"J Oh","year":"2018","unstructured":"Oh J, Bae JY. Optimal cutoff level of serum squamous cell carcinoma antigen to detect recurrent cervical squamous cell carcinoma during post-treatment surveillance. Obstet Gynecol Sci. 2018;61(3):337.","journal-title":"Obstet Gynecol Sci"},{"key":"2040_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13000-016-0499-x","volume":"11","author":"S Huang","year":"2016","unstructured":"Huang S, Qing C, Huang Z, Zhu Y. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis. Diagn Pathol. 2016;11:1\u20137.","journal-title":"Diagn Pathol"},{"issue":"6","key":"2040_CR119","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","volume":"18","author":"RL Setten","year":"2019","unstructured":"Setten RL, Rossi JJ, Han S. The current state and future directions of RNAi-based therapeutics. Nat Rev Drug Discov. 2019;18(6):421\u201346.","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"2040_CR120","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrg3978","volume":"16","author":"A Wittrup","year":"2015","unstructured":"Wittrup A, Lieberman J. Knocking down disease: a progress report on siRNA therapeutics. Nat Rev Genet. 2015;16(9):543\u201352.","journal-title":"Nat Rev Genet"},{"key":"2040_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1156494","volume":"14","author":"P Maroni","year":"2023","unstructured":"Maroni P, Gomarasca M, Lombardi G. Long non-coding RNAs in bone metastasis: progresses and perspectives as potential diagnostic and prognostic biomarkers. Front Endocrinol (Lausanne). 2023;14:1156494.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2040_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03928-w","volume":"12","author":"J Ni","year":"2021","unstructured":"Ni J, Zhang X, Li J, Zheng Z, Zhang J, Zhao W, et al. Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p\/RAC1 signalling axis in osteoclasts. Cell Death Dis. 2021;12(7):662.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2040_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06156-4","volume":"23","author":"X Liu","year":"2025","unstructured":"Liu X, Ma R, Wei F, Wang M, Jiang Y, Zheng P, et al. Tumor-derived exosomal lncRNA-MIR193BHG promotes bone metastasis of breast cancer by targeting the miR-489-3p\/DNMT3A signaling axis in osteoclasts. J Transl Med. 2025;23(1):142.","journal-title":"J Transl Med"},{"key":"2040_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2019.100227","volume":"16","author":"C Spadazzi","year":"2019","unstructured":"Spadazzi C, Recine F, Mercatali L, Miserocchi G, Liverani C, De Vita A, et al. mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model. J Bone Oncol. 2019;16:100227.","journal-title":"J Bone Oncol"},{"key":"2040_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.621278","volume":"11","author":"A Marquardt","year":"2021","unstructured":"Marquardt A, Solimando AG, Kerscher A, Bittrich M, Kalogirou C, K\u00fcbler H, et al. Subgroup-independent mapping of renal cell carcinoma-machine learning reveals prognostic mitochondrial gene signature beyond histopathologic boundaries. Front Oncol. 2021;11:621278.","journal-title":"Front Oncol"},{"key":"2040_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-019-0229-8","volume":"5","author":"K Ibraheem","year":"2019","unstructured":"Ibraheem K, Yhmed AMA, Qayyum T, Bryan NP, Georgopoulos NT. CD40 induces renal cell carcinoma-specific differential regulation of TRAF proteins, ASK1 activation and JNK\/p38-mediated, ROS-dependent mitochondrial apoptosis. Cell Death Discov. 2019;5:148.","journal-title":"Cell Death Discov"},{"issue":"5","key":"2040_CR127","doi-asserted-by":"publisher","first-page":"303","DOI":"10.18869\/acadpub.ibj.21.5.303","volume":"21","author":"S Sarrafzadeh","year":"2017","unstructured":"Sarrafzadeh S, Geranpayeh L, Tasharrofi B, Soudyab M, Nikpayam E, Iranpour M, et al. Expression study and clinical correlations of MYC and CCAT2 in breast cancer patients. Iran Biomed J. 2017;21(5):303\u201311.","journal-title":"Iran Biomed J"},{"issue":"4","key":"2040_CR128","first-page":"706","volume":"21","author":"ZJ Wu","year":"2017","unstructured":"Wu ZJ, Li Y, Wu YZ, Wang Y, Nian WQ, Wang LL, et al. Long non-coding RNA CCAT2 promotes the breast cancer growth and metastasis by regulating TGF-\u03b2 signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(4):706\u201314.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2040_CR129","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020538","author":"H Xie","year":"2023","unstructured":"Xie H, Guo Y, Xu Z, Wang Q, Wang T, Gu Y, et al. Dual function of CCAT2 in regulating luminal subtype of breast cancer depending on the subcellular distribution. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15020538.","journal-title":"Cancers (Basel)"},{"issue":"11","key":"2040_CR130","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23176","volume":"36","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Wang X, Wang Y, Zhou D, Wu H, Cheng W, et al. Effect of long noncoding RNA CCAT2 on drug sensitivity to 5-fluorouracil of breast cancer cells through microRNA-145 meditated by p53. J Biochem Mol Toxicol. 2022;36(11):e23176.","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"2040_CR131","volume":"6","author":"Z Pourramezan","year":"2023","unstructured":"Pourramezan Z, Attar FA, Yusefpour M, Azizi M, Oloomi M. Circulating lncRNAs landscape as potential biomarkers in breast cancer. Cancer Rep (Hoboken). 2023;6(2):e1722.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"5","key":"2040_CR132","first-page":"821","volume":"50","author":"Y Cai","year":"2016","unstructured":"Cai Y, He J, Zhang D. [Suppression of long non-coding RNA CCAT2 improves tamoxifen-resistant breast cancer cells\u2019 response to tamoxifen]. Mol Biol (Mosk). 2016;50(5):821\u20137.","journal-title":"Mol Biol (Mosk)"},{"key":"2040_CR133","doi-asserted-by":"crossref","unstructured":"Dong P, Xiong Y, Yue J, Kobayashi SJBH, Todo N. Y, Exploring lncRNA-Mediated regulatory networks in endometrial cancer cells and the tumor microenvironment: advances and challenges. Cancers (Basel). 2019;11(2).","DOI":"10.3390\/cancers11020234"},{"key":"2040_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212491","author":"R Pirlog","year":"2021","unstructured":"Pirlog R, Drula R, Nutu A, Calin GA, Berindan-Neagoe I. The roles of the colon cancer associated transcript 2 (CCAT2) long non-coding RNA in cancer: a comprehensive characterization of the tumorigenic and molecular functions. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222212491.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2040_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1722","volume":"6","author":"Z Pourramezan","year":"2023","unstructured":"Pourramezan Z, Attar FA, Yusefpour M, Azizi M, Oloomi M. Circulating lncRNAs landscape as potential biomarkers in breast cancer. Cancer Reports. 2023;6(2):e1722.","journal-title":"Cancer Reports"},{"key":"2040_CR136","doi-asserted-by":"crossref","unstructured":"Cai Y, He J, Zhang D. Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway. OncoTargets Therapy. 2015:2657\u201364.","DOI":"10.2147\/OTT.S90485"},{"key":"2040_CR137","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S259586","author":"W-J Wang","year":"2020","unstructured":"Wang W-J, Wang D, Zhao M, Sun X-J, Li Y, Lin H, et al. Serum lncRNAs (CCAT2, LINC01133, LINC00511) with squamous cell carcinoma antigen panel as novel non-invasive biomarkers for detection of cervical squamous carcinoma. Cancer Manag Res. 2020. https:\/\/doi.org\/10.2147\/CMAR.S259586.","journal-title":"Cancer Manag Res"},{"key":"2040_CR138","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00404-018-4740-6","volume":"297","author":"S \u0141a\u017aniak","year":"2018","unstructured":"\u0141a\u017aniak S, Lutkowska A, Ware\u0144czak-Florczak \u017b, Sowi\u0144ska A, Tsibulski A, Roszak A, et al. The association of CCAT2 rs6983267 SNP with MYC expression and progression of uterine cervical cancer in the Polish population. Arch Gynecol Obstet. 2018;297:1285\u201392.","journal-title":"Arch Gynecol Obstet"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02040-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02040-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02040-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T03:03:27Z","timestamp":1770692607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02040-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":138,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2040"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02040-7","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"In this manuscript, ChatGPT and Grammarly were used for paraphrasing and grammatical corrections","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI tools"}}],"article-number":"130"}}